Loading clinical trials...
Loading clinical trials...
Identification of Novel Molecular Pathophysiological Mechanisms of Secondary Brain Injury in Post-cardiac Arrest Syndrome Patients Using Cerebrospinal Fluid Multi-omics Analysis
Conditions
Locations
1
South Korea
Chungnam National University Hospital
Daejeon, Jung-gu, South Korea
Start Date
December 1, 2025
Primary Completion Date
November 30, 2027
Completion Date
February 28, 2028
Last Updated
March 18, 2026
NCT07438938
NCT07363772
NCT06939335
NCT07143357
NCT07216157
NCT06781892
Lead Sponsor
Chungnam National University Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions